5/27/16 17:26  | 5/26/16  | EVOK | Evoke Pharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S | -28 | 4.70 | 0 | -6 | -36 | 10 | D | -28 | 1 | 46 | 61 | 13 | 9 | -6 | 3 | -3 | 0 | 13 | -67 | -67 |  | 
4/27/16 20:37  | 4/25/16  | EVOK | Evoke Pharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | 0 | 5.07 | 0 | 0 | -1 | 16 | D | -45 | -17 | 44 | 56 | 9 | 0 | 9 | 0 | 4 | 2 | 7 | -62 | -58 |  | 
4/21/16 17:12  | 4/19/16  | EVOK | Evoke Pharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -4 | 5.35 | 0 | -1 | -4 | 16 | D | -34 | -21 | 36 | 86 | 23 | 2 | -1 | 9 | -3 | -8 | 5 | -62 | -64 |  | 
4/13/16 19:31  | 4/11/16  | EVOK | Evoke Pharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S | 0 | 5.22 | 0 | 0 | 0 | 17 | D | -31 | -31 | 18 | 85 | 49 | 9 | 1 | -4 | -7 | 1 | -2 | 103 | -59 |  | 
4/8/16 20:51  | 4/6/16  | EVOK | Evoke Pharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -5 | 5.28 | 0 | -1 | -5 | 17 | D | -32 | -25 | 62 | 70 | 59 | 18 | 13 | 3 | 0 | -8 | -5 | 34 | -56 | -41 | 
8/20/15 17:01  | 8/18/15  | EVOK | Evoke Pharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S | -1 | 7.02 | 1 | 0 | -1 | 18 | D |  | -36 | -26 | -25 | -21 | -17 | -10 | -8 | -6 | -9 | -26 | -25 | -20 | -50 | 
4/16/15 19:44  | 4/14/15  | EVOK | Evoke Pharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -6 | 7.29 | 0 | -1 | -5 | 18 | D |  | 5 | 44 | -4 | 37 | 6 | 4 | 2 | 0 | -3 | -10 | -12 | -35 | -25 | 
6/5/13 17:52  | 6/4/13  | CLVS | Clovis Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S | -179 | 64.58 | 29 | -3 | -6 | 44 | D |  | 315 | 381 | 200 | 102 | 86 | 121 | 100 | 3 | 7 | 3 | -6 | -9 | -43 | 
3/22/13 18:16  | 3/21/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S | -5 | 5.49 | 0 | -1 | -2 | 40 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/21/13 17:10  | 3/19/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -1 | 5.20 | 0 | 0 | -1 | 41 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/19/13 16:43  | 3/15/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -2 | 5.23 | 0 | 0 | -1 | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/15/13 16:59  | 3/13/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -1 | 5.38 | 0 | 0 | -1 | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/13/13 20:38  | 3/11/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -1 | 5.36 | 0 | 0 | 0 | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/11/13 18:35  | 3/7/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -2 | 5.25 | 0 | 0 | -1 | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/7/13 18:12  | 3/5/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -1 | 5.03 | 0 | 0 | 0 | 43 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/6/13 18:25  | 3/4/13  | CLVS | Clovis Oncology, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -103 | 24.59 | 2 | -4 | -8 | 47 | D |  | 0 | 35 | 60 | 19 | 28 | 32 | 31 | 3 | 11 | 14 | 199 | 165 | 260 | 
3/5/13 17:18  | 3/1/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -1 | 5.01 | 0 | 0 | -1 | 43 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/22/13 16:53  | 2/20/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S | 0 | 5.01 | 0 | 0 | 0 | 43 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/20/13 16:55  | 2/15/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -1 | 5.02 | 0 | 0 | -1 | 43 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/15/13 17:12  | 2/13/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -1 | 5.00 | 0 | 0 | 0 | 43 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/5/13 18:16  | 2/1/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S | -1 | 4.85 | 0 | 0 | 0 | 43 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/1/13 16:53  | 1/30/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -2 | 4.82 | 0 | -1 | -1 | 44 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/30/13 19:18  | 1/28/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -3 | 5.34 | 0 | -1 | -1 | 44 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/28/13 19:35  | 1/24/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -5 | 5.43 | 0 | -1 | -2 | 45 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/24/13 16:34  | 1/22/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -3 | 5.08 | 0 | -1 | -1 | 45 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/22/13 18:23  | 1/17/13  | CADX | Cadence Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T |  | S.m | -3 | 5.25 | 0 | -1 | -1 | 46 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |